Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanne Koops

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Schizophrenia Research|October 19, 2024
Antipsychotic dopamine D<sub>2</sub> affinity and negative symptoms in remitted first episode psychosis patientsFranciska de Beer, Ben Wijnen, Lotte Wouda, et al.
Schizophrenia Bulletin|August 21, 2025
The Effects of Antipsychotic Dose Reduction on Movement Disorders and Cardiometabolic Indices in Patients Remitted from a First Episode of PsychosisYinzhao Liu, Iris E Sommer, Marieke J H Begemann, et al.
Scientific Reports|January 26, 2026
Correction: Psychiatrists effect on positive symptom severity and daily functioning during pharmacotherapy for first-episode psychosis patientsFranciska de Beer, Sanne Koops, Robert A Schoevers, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 23, 2026
Antipsychotic plasma concentration as predictor of movement disorders and cardiometabolic side-effects: A comparison with prescription doseYinzhao Liu, Iris E Sommer, Georgios Schoretsanitis, et al.
Psychological Medicine|November 17, 2017
White matter abnormalities in 22q11.2 deletion syndrome patients showing cognitive declineJasper Olivier Nuninga, Marc Marijn Bohlken, Sanne Koops, et al.
Journal of Psychiatric Research|December 21, 2024
Associations between momentary mental states and concurrent social functioning after remission from first episode psychosis: A HAMLETT ecological momentary assessment studyMatej Djordjevic, Hannah E Jongsma, Claudia J P Simons, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 15, 2025
Risk of relapse during tapering of antipsychotic medication after a first psychotic episode: association with D2 receptor affinity but not with tapering speedShiral S Gangadin, Franciska de Beer, Ben Wijnen, et al.
Schizophrenia Bulletin|February 18, 2022
Modular-Level Functional Connectome Alterations in Individuals With Hallucinations Across the Psychosis ContinuumMaya J L Schutte, Alban Voppel, Guusje Collin, et al.
Schizophrenia Bulletin|February 25, 2023
Hallucinations in Hearing Impairment: How Informed Are Clinicians?Theresa M Marschall, Pim van Dijk, Karolina Kluk, et al.
Psychological Medicine|January 2, 2026
Negative association between cognitive functioning and antipsychotic D<sub>2</sub> receptor occupancy, affinity, and dose after first episode psychosisPriscilla P Oomen, Shiral S Gangadin, Lieuwe de Haan, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Schizophrenia Research|October 19, 2024
Antipsychotic dopamine D<sub>2</sub> affinity and negative symptoms in remitted first episode psychosis patientsFranciska de Beer, Ben Wijnen, Lotte Wouda, et al.
Schizophrenia Bulletin|August 21, 2025
The Effects of Antipsychotic Dose Reduction on Movement Disorders and Cardiometabolic Indices in Patients Remitted from a First Episode of PsychosisYinzhao Liu, Iris E Sommer, Marieke J H Begemann, et al.
Scientific Reports|January 26, 2026
Correction: Psychiatrists effect on positive symptom severity and daily functioning during pharmacotherapy for first-episode psychosis patientsFranciska de Beer, Sanne Koops, Robert A Schoevers, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 23, 2026
Antipsychotic plasma concentration as predictor of movement disorders and cardiometabolic side-effects: A comparison with prescription doseYinzhao Liu, Iris E Sommer, Georgios Schoretsanitis, et al.
Psychological Medicine|November 17, 2017
White matter abnormalities in 22q11.2 deletion syndrome patients showing cognitive declineJasper Olivier Nuninga, Marc Marijn Bohlken, Sanne Koops, et al.
Journal of Psychiatric Research|December 21, 2024
Associations between momentary mental states and concurrent social functioning after remission from first episode psychosis: A HAMLETT ecological momentary assessment studyMatej Djordjevic, Hannah E Jongsma, Claudia J P Simons, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 15, 2025
Risk of relapse during tapering of antipsychotic medication after a first psychotic episode: association with D2 receptor affinity but not with tapering speedShiral S Gangadin, Franciska de Beer, Ben Wijnen, et al.
Schizophrenia Bulletin|February 18, 2022
Modular-Level Functional Connectome Alterations in Individuals With Hallucinations Across the Psychosis ContinuumMaya J L Schutte, Alban Voppel, Guusje Collin, et al.
Schizophrenia Bulletin|February 25, 2023
Hallucinations in Hearing Impairment: How Informed Are Clinicians?Theresa M Marschall, Pim van Dijk, Karolina Kluk, et al.
Psychological Medicine|January 2, 2026
Negative association between cognitive functioning and antipsychotic D<sub>2</sub> receptor occupancy, affinity, and dose after first episode psychosisPriscilla P Oomen, Shiral S Gangadin, Lieuwe de Haan, et al.
Pageof 6